Jeff Sessions' Retirement Affect On Marijuana

New Post Public Reply Private Reply Replies (0) Message Board
StanleyK
1,435
Jeff Sessions' Retirement Affect On Marijuana Industry

10 Cannabis Executives Predict How AG Jeff Sessions' Retirement Will Affect the Marijuana Industry

When Attorney General Jeff Sessions tendered his resignation on November 7th, the cannabis industry took notice. As one of the most vocal marijuana opponents in the highest level of U.S. government, his resignation could pave the way for federal legalization.

With Matthew Whitaker set to take Sessions’ place, the industry could be poised for significant change in the near future. How do cannabis industry insiders feel about this news? Will it be as groundbreaking as many hope? Here are insights and predictions from 10 cannabis and hemp industry executives to provide some perspective.

Derek Peterson, CEO of Terra Tech

“Attorney General Jeff Sessions has been an impediment to the growth of the regulated cannabis industry. We believe we are at a tipping point nationally in terms of voter sentiment as well as support from lawmakers on both sides of the aisle. With Pete Sessions being voted out [of Congress] and Jeff Sessions resigning, the corridor is now open to accelerate a states’ rights approach to regulating the cannabis industry.”

Isaac Dietrich, CEO of MassRoots

“We believe it’s increasingly likely Congress could take action to regulate and tax cannabis at the federal level. We expect the perceived risks related to the cannabis industry to continue to dissipate, which could lead to a shift of institutional capital and interest from Canadian licensed producers to companies focused on the regulated United States market.”

Charlie Finnie, Chief Strategy Officer of MariMed Inc.

“Although we wish Mr. Sessions well, he was woefully out of step with the American people with regard to the myriad health and wellness benefits of cannabis. When the Republican ex-speaker of the House John Boehner writes an Op-Ed piece entitled 'Cannabis Should be Legalized,' that tells you all you need to know.”

Khurram Malik, CEO of Biome

“AG Sessions’ anti-cannabis rhetoric was a lot stronger than any other part of the federal government, including Congress and the White House, and quite a few things he announced were inconsistent with other parts of the government. Ultimately, most of his anti-cannabis rhetoric and attempted policies did not have a granular impact.

“The hope is that there will be a lot less confusion and distracting noise coming out of the AG’s office on a go forward basis. We also still expect the White House to move forward with legalizing medical cannabis at the federal level before the 2020 elections, and having an AG that is on board with that would be helpful for all.”

Dr. Stuart Titus, CEO of Medical Marijuana Inc.

“The unexpected resignation of U.S. Attorney General Jeff Sessions represents another positive event for the cannabis industry. Sessions' stance on cannabis had been a major impediment toward cannabis reform, and now industry participants hold new hopes for sweeping change at the Federal level. Along with the defeat of Pete Sessions in the U.S. House of Representatives, there is renewed enthusiasm for cannabis-friendly legislation to be passed in the coming year.”

Jeffrey M. Zucker, President of Green Lion Partners

“Jeff Sessions and his ignorance leaving office is a definite win for cannabis patients, the movement and the fight to end the drug war and its racially disparate enforcement as a whole. We’ll have to wait and see how Matthew Whitaker approaches cannabis, but it can’t get much worse than Sessions, and hopefully, this is the start of some federal progress and protection for those participating in cannabis in the many states that have enacted laws. President Trump has seemed amenable to making cannabis a states’ rights issue, and it wouldn’t surprise me if we see changes to that effect on the federal level in the near future.”

George Archos, CEO of Verano Holdings

“The election results send a clear message that more Americans want access to medical or adult-use cannabis because they have taken the time to get educated about cannabis’ proven health benefits. Former AG Sessions and other government officials lose credibility by maintaining that cannabis has no medicinal value when our own FDA has approved a cannabis-derived drug for treating epilepsy.”

“President Trump has repeatedly stated he will protect states’ rights relative to cannabis, and more recently, he stated he is exploring ending the prohibition on cannabis. We are optimistic that a new Attorney General will take President Trump’s cue and quickly reinstate the Cole memo to end ambiguity regarding states’ rights in this matter.”

“Additionally, we hope the new Attorney General will determine that it is not wise to spend tax dollars on incarcerating thousands of people for marijuana convictions when cannabis has been proven to be safer than the alcohol found in almost every American household.”

Wil Ralston, President of SinglePoint

“Jeff Sessions' resignation could be a huge event for the cannabis industry since he has openly been against the industry and used his powers to slow its growth. One of the biggest potentials here is opening up access to banking.”

Frank Lane, President of CFN Media

“The resignation of Jeff Sessions marks another key turning point for the cannabis industry, removing a key obstructionist to cannabis reform from the Justice Department. Many cannabis stocks have already surged following the news in hopes that the resignation will usher in a change to federal cannabis policy, including passage of the STATES Act. We are cautiously optimistic.”

Bruce Perlowin, CEO of Hemp, Inc.

“Sessions has long been a hindrance to the growth of the marijuana and hemp infrastructure in the U.S. and it's a huge win for the industry to see him resign. We are currently in the process of creating jobs for rural farmers throughout the U.S. by creating a chain of local processing centers so farmers can switch to hemp and make a profit, and this latest policy development should lead to real change that can create jobs and spur an agricultural revolution throughout the U.S.”

One thing is clear based on these ten cannabis executives’ perspectives. The resignation of Attorney General Jeff Sessions is expected to be a positive change for the marijuana industry. With more Americans as well as an increasing number of Republicans and Democrats at all levels of government supporting legalization, cannabis-industry insiders see Sessions’ resignation as a key step forward.

Source...

Susan Gunelius
VIP Contributor
Marketing, Branding, Copywriting, Email and Social Media Expert

November 13, 2018
Opinions expressed by Entrepreneur contributors are their own.

Hemp, Inc. (HEMP) Stock Research Links

HEMP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 0

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 1

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
L.L.Bean Teams with Drake and Ann Michael Maye

Updated Category News Views 2

The New Faces of L.L.Bean's Tradition Ah, here we go again with L.L.Bean, spicing things up with a bit of southern flair. This time they've reeled in the Mayes—Drake, that hotshot quarterback from the Patriots, and his better half, Ann Michael. A surprise duo, sure, but that's the kind of refresh the century-old brand could use. They’re all about making New England...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 1

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 1

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
DUNKMAN's Slam Dunk Expansion Plans for 2027

Updated Category News Views 1

More Than Just A Dunk Contest You ever heard of a slam dunk that turns into something bigger than the game itself? Well, Shaquille O'Neal's DUNKMAN is proving just that. Born from the vision of O'Neal and Authentic Brands Group, this beast of an entity isn't just about dunks anymore—it's a whole darn league carving out space in the sporting world. From Inaugural Sparks...

Continue Reading
Pulnovo's PADN System Revolutionizes PH-LHD Treatment

Updated Category News Views 0

Pulnovo's Breakthrough in Heart Disease Management When Pulnovo Medical rolled out the PADN-HF-PH trial results at the ESC Congress 2026, seasoned investors like me sat up and took note. The trial, hot off the presses in The New England Journal of Medicine, unveiled how Pulmonary Artery Denervation (PADN) is throwing a wrench into the gears of conventional treatment of...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 0

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
Graphic Packaging Names Berardinelli as HR Executive

Updated Category News Views 1

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 2

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading

Top 5 Most Recently Viewed Articles

RAPT Therapeutics Set to Unveil Key Clinical Findings Soon

Updated Category News Views 292

RAPT Therapeutics Prepares for Data Release on RPT904 Trial RAPT Therapeutics, Inc. (NASDAQ: RAPT), a biopharmaceutical company dedicated to developing innovative therapies for various inflammatory and immunological diseases, is gearing up to present key topline data. The focus of this report will be on its promising Phase 2 clinical trial of RPT904, specifically aimed at...

Continue Reading
Cohen & Steers Fund Updates on Distribution Sources

Updated Category News Views 148

Cohen & Steers REIT and Preferred and Income Fund, Inc. Acknowledges Distribution Sources This notice is designed for the shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) to provide them with key information about the upcoming sources of distributions. The Fund aims to inform its shareholders about the payments scheduled and the...

Continue Reading
How Emerging Markets Outperform the S&P 500 Right Now

Updated Category News Views 171

Emerging Markets Surge Ahead Emerging markets have demonstrated remarkable resilience and growth, outpacing the S&P 500 by a significant margin in recent years. The iShares Core MSCI Emerging Markets ETF (IEMG) has reported a stunning 44% year-over-year increase, effectively tripling the gains seen by the S&P 500. This performance comes as emerging markets break through...

Continue Reading
Celebrate Creativity with HitPaw's Exciting Easter Sale 2025

Updated Category News Views 112

HitPaw Unveils Exciting Easter Savings for Creators HitPaw, a renowned name in multimedia software solutions, is rolling out an impressive Easter Sale that aims to revolutionize how creators work with digital media. As the bright colors of Easter remind us of creativity and renewal, HitPaw is launching its 'Hop into Easter Savings' promotion to empower users in the...

Continue Reading
Walmart Options Trading Insights: What Investors Should Know

Updated Category News Views 64

Notable Trends in Walmart's Options Trading Walmart's recent options trading activity has caught the attention of investors. It seems that wealthy traders are adopting a bearish view on Walmart (WMT), sparking questions about the potential direction of the stock market. There’s been some unusual options activity that points to possible changes in market sentiment. Our...

Continue Reading